John Baker

John Baker is the Chief Executive Officer of IMU Biosciences, a London-based biotechnology company focused on decoding the immune system for precision medicine. He joined IMU Biosciences in September 2024, having previously served as Senior Vice President of Supply Chain and Manufacturing at Abcam, where he was part of the executive team during the company's approximately $5.7 billion acquisition by Danaher Corporation in 2023. He trained as a veterinarian at Cambridge and earned a DPhil in Clinical Medicine from Oxford, and also spent six years as a leader in Bain and Company's Global Healthcare Practice.